| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phospholipid binding | SPTBN4 DENND1B SNX24 GAS6 CGAS PACSIN3 APOB SMPD3 ZFYVE1 RPH3A MTSS2 | 8.87e-06 | 548 | 78 | 11 | GO:0005543 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-phosphate 4-kinase activity | 4.51e-05 | 3 | 78 | 2 | GO:0016309 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 1.29e-04 | 199 | 78 | 6 | GO:1901981 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PLEKHG1 DENND1B MYO9B DENND4B ITSN1 RALGPS2 ARHGEF2 SEC23A MTSS2 | 1.57e-04 | 507 | 78 | 9 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PLEKHG1 DENND1B MYO9B DENND4B ITSN1 RALGPS2 ARHGEF2 SEC23A MTSS2 | 1.57e-04 | 507 | 78 | 9 | GO:0030695 |
| GeneOntologyMolecularFunction | small GTPase binding | 2.59e-04 | 321 | 78 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.88e-04 | 231 | 78 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | GTPase binding | 5.15e-04 | 360 | 78 | 7 | GO:0051020 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 5.33e-04 | 9 | 78 | 2 | GO:0016308 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 8.10e-04 | 11 | 78 | 2 | GO:0047676 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.48e-03 | 316 | 78 | 6 | GO:0035091 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 1.53e-03 | 15 | 78 | 2 | GO:0004467 | |
| GeneOntologyMolecularFunction | lipid binding | SPTBN4 DENND1B SNX24 GAS6 CGAS PACSIN3 APOB SMPD3 ZFYVE1 RPH3A MTSS2 | 1.53e-03 | 988 | 78 | 11 | GO:0008289 |
| Domain | PInositol-4-P-5-kinase | 3.57e-04 | 7 | 78 | 2 | IPR023610 | |
| Domain | PIPKc | 4.74e-04 | 8 | 78 | 2 | SM00330 | |
| Domain | - | 4.74e-04 | 8 | 78 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 4.74e-04 | 8 | 78 | 2 | PF01504 | |
| Domain | PIPK | 4.74e-04 | 8 | 78 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 4.74e-04 | 8 | 78 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 4.74e-04 | 8 | 78 | 2 | IPR027483 | |
| Domain | - | 4.74e-04 | 8 | 78 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 4.74e-04 | 8 | 78 | 2 | IPR002498 | |
| Domain | GDS_CDC24_CS | 5.75e-04 | 39 | 78 | 3 | IPR001331 | |
| Domain | uDENN | 1.52e-03 | 14 | 78 | 2 | SM00800 | |
| Domain | uDENN | 1.75e-03 | 15 | 78 | 2 | PF03456 | |
| Domain | UDENN | 1.99e-03 | 16 | 78 | 2 | PS50946 | |
| Domain | DDENN | 1.99e-03 | 16 | 78 | 2 | PS50947 | |
| Domain | DENN | 1.99e-03 | 16 | 78 | 2 | SM00799 | |
| Domain | dDENN | 1.99e-03 | 16 | 78 | 2 | SM00801 | |
| Domain | DENN | 1.99e-03 | 16 | 78 | 2 | PF02141 | |
| Domain | dDENN_dom | 1.99e-03 | 16 | 78 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.99e-03 | 16 | 78 | 2 | IPR005113 | |
| Domain | dDENN | 1.99e-03 | 16 | 78 | 2 | PF03455 | |
| Domain | DENN | 1.99e-03 | 16 | 78 | 2 | PS50211 | |
| Domain | DENN_dom | 1.99e-03 | 16 | 78 | 2 | IPR001194 | |
| Domain | DH_1 | 2.32e-03 | 63 | 78 | 3 | PS00741 | |
| Domain | zf-C2H2 | HIVEP3 PRDM10 HIVEP2 ZNF337 ZNF584 ZNF451 ZBTB41 ZIC3 ZNF445 | 2.35e-03 | 693 | 78 | 9 | PF00096 |
| Domain | CH | 2.54e-03 | 65 | 78 | 3 | SM00033 | |
| Domain | PH | 2.71e-03 | 229 | 78 | 5 | PF00169 | |
| Domain | RhoGEF | 2.89e-03 | 68 | 78 | 3 | SM00325 | |
| Domain | RhoGEF | 3.14e-03 | 70 | 78 | 3 | PF00621 | |
| Domain | CH | 3.14e-03 | 70 | 78 | 3 | PF00307 | |
| Domain | DH_2 | 3.14e-03 | 70 | 78 | 3 | PS50010 | |
| Domain | DH-domain | 3.27e-03 | 71 | 78 | 3 | IPR000219 | |
| Domain | - | 3.27e-03 | 71 | 78 | 3 | 1.20.900.10 | |
| Domain | - | 3.27e-03 | 71 | 78 | 3 | 1.10.418.10 | |
| Domain | CH | 3.53e-03 | 73 | 78 | 3 | PS50021 | |
| Domain | Znf_C2H2_jaz | 3.77e-03 | 22 | 78 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 3.77e-03 | 22 | 78 | 2 | PF12171 | |
| Domain | CH-domain | 3.81e-03 | 75 | 78 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 4.12e-03 | 23 | 78 | 2 | IPR001589 | |
| Domain | Spectrin | 4.12e-03 | 23 | 78 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.12e-03 | 23 | 78 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.12e-03 | 23 | 78 | 2 | PS00019 | |
| Domain | SH3_9 | 4.26e-03 | 78 | 78 | 3 | PF14604 | |
| Domain | Cadherin_cytoplasmic-dom | 4.85e-03 | 25 | 78 | 2 | IPR000233 | |
| Domain | Cadherin_C | 4.85e-03 | 25 | 78 | 2 | PF01049 | |
| Domain | ZINC_FINGER_C2H2_2 | HIVEP3 PRDM10 HIVEP2 ZNF337 ZNF584 ZNF451 ZBTB41 ZIC3 ZNF445 | 4.91e-03 | 775 | 78 | 9 | PS50157 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RPL10A EHBP1 RAD18 DENND1B SNX24 PACSIN3 SMN1 DMD R3HDM1 CDC27 ZFYVE1 SEC23A RPAP2 | 5.90e-07 | 1038 | 79 | 13 | 26673895 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CLGN INCENP GAS6 CHEK2 PIP4K2B SRPK1 PIP4K2C ARHGEF2 CDC27 NKAPL STK24 STK25 | 9.82e-07 | 910 | 79 | 12 | 36736316 |
| Pubmed | 1.34e-06 | 10 | 79 | 3 | 25578879 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL10A ACSL3 INCENP MYO9B CGAS SRPK1 RPS24 PRR11 PIP4K2C ARHGEF2 CDC27 SEC23A ZBED5 FTSJ3 | 1.99e-06 | 1353 | 79 | 14 | 29467282 |
| Pubmed | Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways. | 5.09e-06 | 2 | 79 | 2 | 19855390 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32692911 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 35130716 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20404140 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34081545 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29859927 | ||
| Pubmed | Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties. | 5.09e-06 | 2 | 79 | 2 | 2247438 | |
| Pubmed | 8.69e-06 | 210 | 79 | 6 | 16565220 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 30718367 | ||
| Pubmed | Mrc1 channels the DNA replication arrest signal to checkpoint kinase Cds1. | 1.53e-05 | 3 | 79 | 2 | 11715017 | |
| Pubmed | Mitochondrial glycerol 3-phosphate dehydrogenase promotes skeletal muscle regeneration. | 1.53e-05 | 3 | 79 | 2 | 30389681 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25495341 | ||
| Pubmed | An ATM-Chk2-INCENP pathway activates the abscission checkpoint. | 1.53e-05 | 3 | 79 | 2 | 33355621 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 23889253 | ||
| Pubmed | Dampening of death pathways by schnurri-2 is essential for T-cell development. | 1.53e-05 | 3 | 79 | 2 | 21475200 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 23758345 | ||
| Pubmed | 7',5'-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy. | 1.53e-05 | 3 | 79 | 2 | 34850138 | |
| Pubmed | The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis. | 1.53e-05 | 3 | 79 | 2 | 26774281 | |
| Pubmed | 1.75e-05 | 653 | 79 | 9 | 22586326 | ||
| Pubmed | SPTBN4 ACSL3 ARMC3 ITSN1 PIP4K2B ATP11C ZBTB41 APOB DMD ARHGEF2 NEB CDC27 RPL3L | 2.09e-05 | 1442 | 79 | 13 | 35575683 | |
| Pubmed | 2.67e-05 | 689 | 79 | 9 | 36543142 | ||
| Pubmed | A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. | 3.05e-05 | 4 | 79 | 2 | 9367159 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 36692953 | ||
| Pubmed | PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism. | 3.05e-05 | 4 | 79 | 2 | 31091439 | |
| Pubmed | RAD18 ITSN1 RALGPS2 ZBTB41 APOB RPS24 CDC27 ZFYVE1 STK24 STK25 ZNF445 | 3.34e-05 | 1084 | 79 | 11 | 11544199 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.72e-05 | 552 | 79 | 8 | 10737800 | |
| Pubmed | 4.32e-05 | 733 | 79 | 9 | 34672954 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.64e-05 | 759 | 79 | 9 | 35915203 | |
| Pubmed | 7.01e-05 | 35 | 79 | 3 | 33378683 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 32934012 | ||
| Pubmed | CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. | 7.60e-05 | 6 | 79 | 2 | 17657516 | |
| Pubmed | Structural basis for the selective activation of Rho GTPases by Dbl exchange factors. | 7.60e-05 | 6 | 79 | 2 | 12006984 | |
| Pubmed | Pdcd10-Stk24/25 complex controls kidney water reabsorption by regulating Aqp2 membrane targeting. | 7.60e-05 | 6 | 79 | 2 | 34156031 | |
| Pubmed | 7.69e-05 | 191 | 79 | 5 | 31177093 | ||
| Pubmed | 9.76e-05 | 634 | 79 | 8 | 34591612 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 1.03e-04 | 106 | 79 | 4 | 31024071 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 15018809 | ||
| Pubmed | CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation. | 1.06e-04 | 7 | 79 | 2 | 20332113 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 12176734 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 22291017 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL10A GPD2 ACSL3 DSG2 RBM12B MYO9B PACSIN3 ARHGEF2 SEC23A FTSJ3 | 1.07e-04 | 1024 | 79 | 10 | 24711643 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | GMNC PLEKHG1 RAD18 METTL24 DENND1B RALGPS2 PACSIN3 SEC23A ZBED5 MTSS2 RPAP2 | 1.13e-04 | 1242 | 79 | 11 | 30973865 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL10A INCENP DSG2 RBM12B CGAS PACSIN3 SRPK1 SMN1 RPS24 ARHGEF2 FTSJ3 | 1.25e-04 | 1257 | 79 | 11 | 36526897 |
| Pubmed | RPL10A ACSL3 PLEKHG1 EXOC5 DSG2 ZNF451 ITSN1 TOMM34 SRPK1 PRR11 HERC5 FTSJ3 | 1.29e-04 | 1487 | 79 | 12 | 33957083 | |
| Pubmed | 1.29e-04 | 491 | 79 | 7 | 36273042 | ||
| Pubmed | 1.34e-04 | 215 | 79 | 5 | 35973513 | ||
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 1.41e-04 | 8 | 79 | 2 | 28826662 | |
| Pubmed | Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. | 1.41e-04 | 8 | 79 | 2 | 15719014 | |
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 15046600 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 PLEKHG1 HIVEP2 DENND1B DSG2 RALGPS2 ARHGEF2 R3HDM1 MTSS2 | 1.47e-04 | 861 | 79 | 9 | 36931259 |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 1.49e-04 | 220 | 79 | 5 | 34091597 | |
| Pubmed | SPTBN4 HIVEP2 ZNF584 ZNF451 ITSN1 RPS24 SMPD3 R3HDM1 RPH3A ZBED5 ZIC3 | 1.52e-04 | 1285 | 79 | 11 | 35914814 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 1.59e-04 | 223 | 79 | 5 | 33187986 | |
| Pubmed | 1.71e-04 | 121 | 79 | 4 | 34029587 | ||
| Pubmed | STK25 and MST3 Have Overlapping Roles to Regulate Rho GTPases during Cortical Development. | 1.82e-04 | 9 | 79 | 2 | 34518307 | |
| Pubmed | 2.14e-04 | 533 | 79 | 7 | 25544563 | ||
| Pubmed | 2.27e-04 | 10 | 79 | 2 | 20949042 | ||
| Pubmed | 2.32e-04 | 131 | 79 | 4 | 28031328 | ||
| Pubmed | 2.50e-04 | 547 | 79 | 7 | 37267103 | ||
| Pubmed | DSG2 ZNF451 PACSIN3 IREB2 SRPK1 SMN1 APOB PRR11 ARHGEF2 SEC23A FTSJ3 | 2.65e-04 | 1371 | 79 | 11 | 36244648 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RAD18 CEP120 INCENP DSG2 SNX24 ZNF451 CHEK2 PACSIN3 CDC27 STK25 | 2.83e-04 | 1155 | 79 | 10 | 20360068 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.63e-04 | 582 | 79 | 7 | 20467437 | |
| Pubmed | 4.01e-04 | 421 | 79 | 6 | 36976175 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 4.59e-04 | 432 | 79 | 6 | 23455922 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.06e-04 | 440 | 79 | 6 | 34244565 | |
| Pubmed | 5.12e-04 | 441 | 79 | 6 | 31239290 | ||
| Pubmed | 5.39e-04 | 622 | 79 | 7 | 14574404 | ||
| Pubmed | 5.43e-04 | 446 | 79 | 6 | 24255178 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPL10A GPD2 EHBP1 ACSL3 INCENP RPS24 PRR11 ARHGEF2 R3HDM1 SEC23A FTSJ3 | 5.53e-04 | 1496 | 79 | 11 | 32877691 |
| Pubmed | Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. | 5.69e-04 | 166 | 79 | 4 | 27160897 | |
| Pubmed | 6.51e-04 | 74 | 79 | 3 | 29795351 | ||
| Pubmed | 8.48e-04 | 486 | 79 | 6 | 20936779 | ||
| Pubmed | 8.50e-04 | 19 | 79 | 2 | 18329113 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 9.22e-04 | 328 | 79 | 5 | 23398456 | |
| Pubmed | Can we predict top-level sports performance in power vs endurance events? A genetic approach. | 9.43e-04 | 20 | 79 | 2 | 20459474 | |
| Pubmed | 9.56e-04 | 686 | 79 | 7 | 29987050 | ||
| Pubmed | 9.74e-04 | 85 | 79 | 3 | 36517592 | ||
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 9.79e-04 | 192 | 79 | 4 | 32176739 | |
| Pubmed | 1.04e-03 | 21 | 79 | 2 | 21943158 | ||
| Pubmed | 1.04e-03 | 87 | 79 | 3 | 15189156 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL10A GPD2 ACSL3 RAD18 DSG2 PACSIN3 TOMM34 RPS24 CDC27 SEC23A | 1.04e-03 | 1367 | 79 | 10 | 32687490 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 1.11e-03 | 704 | 79 | 7 | 32994395 | |
| Pubmed | 1.12e-03 | 513 | 79 | 6 | 25798074 | ||
| Pubmed | 1.14e-03 | 22 | 79 | 2 | 12812986 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.20e-03 | 714 | 79 | 7 | 28302793 | |
| Pubmed | Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. | 1.25e-03 | 23 | 79 | 2 | 24925725 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL10A GPD2 PACSIN3 SRPK1 RPS24 PIP4K2C ARHGEF2 SEC23A RPAP2 FTSJ3 | 1.35e-03 | 1415 | 79 | 10 | 28515276 |
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | 1.41e-03 | 361 | 79 | 5 | 18976975 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.43e-03 | 1425 | 79 | 10 | 30948266 | |
| Pubmed | RPL10A SPTBN4 GPD2 ITSN1 RPS24 DMD PIP4K2C ARHGEF2 RPH3A SEC23A | 1.47e-03 | 1431 | 79 | 10 | 37142655 | |
| Pubmed | 1.60e-03 | 101 | 79 | 3 | 10997877 | ||
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 1.62e-03 | 220 | 79 | 4 | 31822558 | |
| Pubmed | 1.69e-03 | 103 | 79 | 3 | 10574462 | ||
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 1.72e-03 | 27 | 79 | 2 | 18468998 | |
| Pubmed | 1.75e-03 | 560 | 79 | 6 | 35241646 | ||
| Pubmed | 1.80e-03 | 382 | 79 | 5 | 37249651 | ||
| Interaction | KIF23 interactions | RPL10A ACSL3 INCENP DSG2 RBM12B MYO9B ZNF451 PACSIN3 SRPK1 SMN1 RPS24 PRR11 DMD ARHGEF2 STK24 SEC23A HERC5 FTSJ3 | 7.07e-08 | 1031 | 79 | 18 | int:KIF23 |
| Interaction | PAGE1 interactions | 1.31e-05 | 37 | 79 | 4 | int:PAGE1 | |
| Interaction | PRKRA interactions | 2.64e-05 | 400 | 79 | 9 | int:PRKRA | |
| Cytoband | 1q31.3 | 3.45e-04 | 16 | 79 | 2 | 1q31.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q23 | 1.11e-03 | 117 | 79 | 3 | chr5q23 | |
| Cytoband | 5q23.2 | 1.40e-03 | 32 | 79 | 2 | 5q23.2 | |
| Cytoband | 6p21.31 | 2.30e-03 | 41 | 79 | 2 | 6p21.31 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | HIVEP3 PRDM10 HIVEP2 ZNF337 ZNF584 ZNF451 ZBTB41 ZIC3 ZNF445 | 3.81e-04 | 718 | 57 | 9 | 28 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.73e-04 | 206 | 57 | 5 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.18e-03 | 66 | 57 | 3 | 722 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 1.79e-03 | 20 | 57 | 2 | 1371 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.80e-03 | 25 | 57 | 2 | 504 | |
| GeneFamily | Acyl-CoA synthetase family | 3.02e-03 | 26 | 57 | 2 | 40 | |
| GeneFamily | Methyltransferase like | 4.84e-03 | 33 | 57 | 2 | 963 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN | 2.86e-05 | 196 | 79 | 6 | M6160 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN | 2.86e-05 | 196 | 79 | 6 | M8757 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | 3.11e-05 | 199 | 79 | 6 | M8770 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | EXOC5 METTL5 CEP120 DENND1B ZNF451 ATP11C ZBTB41 RPS24 SEC23A HERC5 | 4.05e-05 | 687 | 79 | 10 | M41022 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 ACSL3 HIVEP2 MYO9B ZNF451 ITSN1 ATAD2B DMD R3HDM1 CDC27 STK24 | 5.04e-05 | 856 | 79 | 11 | M4500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | GPD2 FBXO25 METTL24 DENND1B AFF2 DSG2 SLC27A6 RGS22 GAS6 TEX15 NKAPL STK24 CDH12 MTSS2 RPAP2 | 2.29e-07 | 803 | 79 | 15 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | METTL24 DENND1B AFF2 DSG2 RGS22 GAS6 RALGPS2 TEX15 STK24 MTSS2 | 2.49e-06 | 404 | 79 | 10 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.43e-06 | 259 | 79 | 8 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.45e-05 | 231 | 79 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 1.60e-04 | 137 | 79 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | METTL24 DENND1B AFF2 DSG2 RGS22 GAS6 RALGPS2 TEX15 STK24 CDH12 MTSS2 | 1.60e-04 | 791 | 79 | 11 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.06e-07 | 183 | 79 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 163 | 79 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 165 | 79 | 5 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-05 | 177 | 79 | 5 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 180 | 79 | 5 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-05 | 183 | 79 | 5 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 184 | 79 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 186 | 79 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 190 | 79 | 5 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | B_cell_maturation-Naive_B_cell|World / Lineage and Cell class | 2.34e-05 | 192 | 79 | 5 | 58267a11c938a380c6e26f4e4ce63f3b4be79fdc | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 194 | 79 | 5 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 2.46e-05 | 194 | 79 | 5 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.52e-05 | 195 | 79 | 5 | ecaaa3d071e763c40d05d088fbf9e8ca06f78f47 | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 2.52e-05 | 195 | 79 | 5 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 2.65e-05 | 197 | 79 | 5 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.85e-05 | 200 | 79 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 6.20e-05 | 120 | 79 | 4 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 8.20e-05 | 129 | 79 | 4 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 8.45e-05 | 130 | 79 | 4 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.16e-04 | 141 | 79 | 4 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 144 | 79 | 4 | 4f46a22dba047d35076e7768e834b0cbcecc8417 | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 1.32e-04 | 146 | 79 | 4 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | Healthy-B_cell|Healthy / disease group, cell group and cell class | 1.58e-04 | 153 | 79 | 4 | 7f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 1.62e-04 | 154 | 79 | 4 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 155 | 79 | 4 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 156 | 79 | 4 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 156 | 79 | 4 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 156 | 79 | 4 | 8790b4b400695571fcf1ccb24c658b5e90854ff7 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-04 | 158 | 79 | 4 | 216b3f482daa2d0d7fcaf5a8559e3ccbdb8e110d | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.79e-04 | 158 | 79 | 4 | 9712bb8b1bacb8a38c99a22bc2babec5d5160e2a | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 1.88e-04 | 160 | 79 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 1.97e-04 | 162 | 79 | 4 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-04 | 168 | 79 | 4 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 169 | 79 | 4 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.37e-04 | 170 | 79 | 4 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-04 | 170 | 79 | 4 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.37e-04 | 170 | 79 | 4 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 2.48e-04 | 172 | 79 | 4 | f16f90d17feac1ee52fd513907b28456865fd31d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.53e-04 | 173 | 79 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 174 | 79 | 4 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-04 | 175 | 79 | 4 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-04 | 175 | 79 | 4 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-04 | 176 | 79 | 4 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 2.70e-04 | 176 | 79 | 4 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group,lineage and cell class (2021.01.30) | 2.70e-04 | 176 | 79 | 4 | baa3563973ea1a351fe028f55828463d2a51bf1a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.70e-04 | 176 | 79 | 4 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 2.76e-04 | 177 | 79 | 4 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-04 | 177 | 79 | 4 | 325c10674b18727ddd50bf088a9c6f4ef29aa809 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 177 | 79 | 4 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.82e-04 | 178 | 79 | 4 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | mild-Lymphocytic-B_cells_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.82e-04 | 178 | 79 | 4 | c6fb21401ad802a57e4e4f5a1723c42779fdb33e | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.82e-04 | 178 | 79 | 4 | 499640cfb1063aa40343ec1563e40fe4645466fb | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.82e-04 | 178 | 79 | 4 | 851fdcf1451880a048885cc6677b4edfff6aee4c | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-04 | 178 | 79 | 4 | 1a3b3b73e81ceb26cec8153cd1bdd7b446887a71 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 179 | 79 | 4 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-04 | 180 | 79 | 4 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.95e-04 | 180 | 79 | 4 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-04 | 180 | 79 | 4 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.95e-04 | 180 | 79 | 4 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.01e-04 | 181 | 79 | 4 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 3.01e-04 | 181 | 79 | 4 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.07e-04 | 182 | 79 | 4 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.07e-04 | 182 | 79 | 4 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-04 | 183 | 79 | 4 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 185 | 79 | 4 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 3.27e-04 | 185 | 79 | 4 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | critical-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.27e-04 | 185 | 79 | 4 | 4a5d1d0a757f1f4fdb911be96ed90b52182c25f0 | |
| ToppCell | URO-Lymphocyte-B|URO / Disease, Lineage and Cell Type | 3.34e-04 | 186 | 79 | 4 | c46ff4fc280b67a454ee9614e93c6854a5a400b8 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-04 | 186 | 79 | 4 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|World / Lineage, cell class and subclass | 3.40e-04 | 187 | 79 | 4 | 904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 3.40e-04 | 187 | 79 | 4 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | Leuk-UTI-Lymphocyte-B|Leuk-UTI / Disease, Lineage and Cell Type | 3.40e-04 | 187 | 79 | 4 | a16101d427398da286d48241f2dc024e5483597f | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 3.40e-04 | 187 | 79 | 4 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | lymphoid-B_cell|World / Lineage, cell class and subclass | 3.40e-04 | 187 | 79 | 4 | 2abbc01fd7f5b4e52113699625287893c991f8da | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.47e-04 | 188 | 79 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.47e-04 | 188 | 79 | 4 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-04 | 188 | 79 | 4 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 3.54e-04 | 189 | 79 | 4 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.54e-04 | 189 | 79 | 4 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Immature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.54e-04 | 189 | 79 | 4 | 5776f842b3047d21ccdc44db884bfd210823c7da | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|lymphoid / Lineage, cell class and subclass | 3.62e-04 | 190 | 79 | 4 | b8b05894e811e431d797ac4fa3ccff4963a154e7 | |
| ToppCell | lymphoid-B_cell|lymphoid / Lineage, cell class and subclass | 3.62e-04 | 190 | 79 | 4 | c451de643ee08c2ff1093e807c65d724237473c5 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-04 | 190 | 79 | 4 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 3.62e-04 | 190 | 79 | 4 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-04 | 190 | 79 | 4 | 1f445f24daf4e0e599ee322835b9223ba0e7a1bd | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.69e-04 | 191 | 79 | 4 | 2feab42ac6d29fa4eac78f3f78a5f8aa0a559523 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-04 | 191 | 79 | 4 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.69e-04 | 191 | 79 | 4 | 03f6da73e7b706252d2096507222229c4101a27b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.69e-04 | 191 | 79 | 4 | 578b58782e816ecaeabfbc616ceb1dcd53ee428b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.69e-04 | 191 | 79 | 4 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.69e-04 | 191 | 79 | 4 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-B_naive|ICU-NoSEP / Disease, Lineage and Cell Type | 3.69e-04 | 191 | 79 | 4 | f430961a94890fe8755d22e53836be39cb08e153 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Follicular_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.69e-04 | 191 | 79 | 4 | f400fce79aacf029e20b6dca59d3e17bb2375f28 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.69e-04 | 191 | 79 | 4 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.69e-04 | 191 | 79 | 4 | d4496994dd973eb6d0d8b9101a390af237e12fb2 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_naive|ICU-SEP / Disease, Lineage and Cell Type | 3.69e-04 | 191 | 79 | 4 | a090f9ea58a700c995c4ad35eeebb699f07040f7 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.69e-04 | 191 | 79 | 4 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 3.69e-04 | 191 | 79 | 4 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.87e-05 | 60 | 77 | 4 | C4722327 | |
| Disease | Prostate cancer, familial | 3.26e-05 | 69 | 77 | 4 | C2931456 | |
| Disease | obsolete_red blood cell distribution width | EHBP1 PLEKHG1 DENND1B SLC27A6 MYO9B ITSN1 ATAD2B GAS6 CHEK2 ATP11C APOB R3HDM1 ZFYVE1 | 4.25e-05 | 1347 | 77 | 13 | EFO_0005192 |
| Disease | endometriosis, unipolar depression | 1.96e-04 | 43 | 77 | 3 | EFO_0001065, EFO_0003761 | |
| Disease | coronary artery disease | EHBP1 PLEKHG1 HIVEP2 CEP120 DENND1B SLC27A6 MYO9B PIP4K2B APOB STK24 RPH3A | 2.63e-04 | 1194 | 77 | 11 | EFO_0001645 |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.64e-04 | 11 | 77 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 5.15e-04 | 13 | 77 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | SPTBN4 HIVEP3 PLEKHG1 CLGN CEP120 DENND1B ATAD2B RALGPS2 ZBTB41 RPH3A STK25 | 9.45e-04 | 1392 | 77 | 11 | EFO_0005763 |
| Disease | anorectal malformation | 1.12e-03 | 19 | 77 | 2 | MONDO_0019938 | |
| Disease | mean reticulocyte volume | 1.13e-03 | 799 | 77 | 8 | EFO_0010701 | |
| Disease | influenza A (H1N1) | 1.55e-03 | 87 | 77 | 3 | EFO_1001488 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.10e-03 | 26 | 77 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | wellbeing measurement | 2.20e-03 | 692 | 77 | 7 | EFO_0007869 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.24e-03 | 99 | 77 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | gastroesophageal reflux disease | 2.37e-03 | 101 | 77 | 3 | EFO_0003948 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.44e-03 | 102 | 77 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | complement factor H-related protein 2 measurement | 2.61e-03 | 29 | 77 | 2 | EFO_0600055 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKLKKDHAMKYSRSL | 1171 | P51816 | |
| FCSRHSKALKLYKEL | 341 | Q92974 | |
| RSSKEKNKKNSYHFS | 636 | Q5W041 | |
| LKNKFRTKRYFAKHP | 3376 | P11532 | |
| KRTDKYRTYSKKHFR | 131 | O96017 | |
| DKKHLDKFSSYHVKT | 426 | Q8N884 | |
| VNKFKLRTSKKHYDF | 1076 | Q15032 | |
| FKTLKDYNTALSLHK | 331 | Q8IXT5 | |
| DEIHSKYRKKHKSEF | 336 | Q9NS91 | |
| SHKKFFDVSKLGTKY | 21 | P48200 | |
| NKAAFHKSIRSKYKP | 356 | Q14126 | |
| DRYKKRFHKFDADQK | 626 | P43304 | |
| FKKSKPRYHKRTSSA | 881 | Q9NQS7 | |
| KIDKHNYLTAKDFLK | 1011 | Q9ULI0 | |
| AKEYKRARHEIKKKS | 126 | Q765P7 | |
| EYASKKRKKDHFRND | 61 | Q8TCJ0 | |
| YCDKVYKSASKRKAH | 776 | Q9NQV6 | |
| YKSASKRKAHILKNH | 781 | Q9NQV6 | |
| SKLLYKASVVKKAAA | 321 | Q9NY59 | |
| LKIESKKHKAYLRSA | 651 | Q9UII4 | |
| LPASYKFHKKKSVDI | 186 | Q9NRN9 | |
| DRFSEVKSKIASKYH | 176 | O00471 | |
| SHAKEKLTALTKKYR | 2136 | P04114 | |
| ERKLESATKSKLHYK | 831 | Q8N960 | |
| SVALVDYHSTKKLKK | 536 | Q14393 | |
| RKFLHSGKLYKAKSN | 1461 | Q15811 | |
| YSYSRDLDLAKKKHA | 766 | Q8NDI1 | |
| FDKKYKSAFNKLASS | 1451 | O75064 | |
| IKKYYHISSSAEKKI | 1311 | A4D0S4 | |
| KKAYTFKVEASNLHL | 341 | P55289 | |
| YHKDNKELSVFKKFS | 51 | Q96LA5 | |
| TAYKFAKNHAKLGLK | 446 | Q6P3S1 | |
| KFHRASVLFANEKYK | 706 | P30260 | |
| EASKKSYHAARKDEK | 151 | Q9UKS6 | |
| LTQYDAKKKAAHAAK | 376 | Q8TBX8 | |
| YAAKSLKATERKHFK | 496 | Q86X27 | |
| TSLCFKLYAKGKHEK | 656 | P22897 | |
| QKDFRLFHSYKDLSK | 326 | Q5JXM2 | |
| FFYDIKHSDLAKKSL | 621 | Q9Y2J0 | |
| KAKKLLSSDEFSKAY | 126 | A6NCL1 | |
| RRFYKDWHKSKKKAF | 116 | Q92901 | |
| YFRKLQALHKETFSK | 801 | Q8NE09 | |
| LKHKFILRNAKKTSY | 281 | Q9Y6E0 | |
| SISKHEKAKYEALAK | 51 | Q8WW32 | |
| LTPYDTKKKAAHAAK | 371 | P78356 | |
| KVGKSRRDKFYHLAK | 6 | Q8IY81 | |
| KAYDKAVASFKHALK | 41 | Q16637 | |
| YSKEFFTKKGDLKHI | 586 | Q96SB4 | |
| AKELLKHKFITRYTK | 261 | O00506 | |
| AKYVKKGTKHFEALA | 321 | Q15436 | |
| QIYKAARKSAAKHKF | 261 | P34969 | |
| DAFKLKRKELKTHYQ | 696 | O95573 | |
| DLKKFFTDRKTHLYT | 216 | O14967 | |
| RNSDYSVPKFKHLKK | 846 | Q8NB49 | |
| NKSSKRKHRKYSDSD | 191 | Q5M9Q1 | |
| GKSFKAKYKLVNHIR | 306 | O60481 | |
| HKALKDYKSSFADIS | 271 | Q15785 | |
| YKFTASASHTERKLK | 831 | Q9Y4E5 | |
| EKRYSEFHALHKKLK | 36 | Q9Y343 | |
| KKSAEHFKRKFAKSN | 331 | Q8IXW5 | |
| YSKVKEAFSKKHQRK | 21 | Q96PN8 | |
| ATFKRKDKLKYHIDH | 731 | Q5SVQ8 | |
| LARHGLYEKKKTSRK | 91 | P62847 | |
| GFSFKTKSNLYKHRK | 226 | Q5T1R4 | |
| KDKFFAYLTLAKHTI | 131 | P14679 | |
| TSEVASDYKKKKHVF | 2481 | Q9H254 | |
| KKLAKKYDAFLASES | 101 | P62906 | |
| AYLKHFTKELKATTA | 286 | Q9HBF4 | |
| KHAAYKDKDISFFKQ | 156 | Q49AG3 | |
| KDFAYRSAFIVHKKK | 716 | P59923 | |
| TKKRDDTFTYKAHIL | 351 | Q9ULL1 | |
| LKKPASYVSDFKEKH | 1591 | Q9BXT5 | |
| YKHTKDKLLCDVFKK | 441 | Q9Y2P4 | |
| FKTKSNLYKHRKSHA | 226 | P31629 | |
| KRIASKVKHFAFDRK | 351 | Q6PJF5 | |
| KVKHFAFDRKKRHYG | 356 | Q6PJF5 | |
| ERLFKKKEASHFQSK | 16 | Q96HE9 | |
| KAFSYPSKLRKHQKV | 221 | Q8IVC4 | |
| KFSNKSYYSKHLKRH | 721 | Q9Y3M9 | |
| FKRLFLHKTKDKKYS | 1416 | Q13459 | |
| KHAADIFSEKKYRTK | 4136 | P20929 |